Open Access

Sevoflurane alleviates LPS‑induced acute lung injury via the microRNA‑27a‑3p/TLR4/MyD88/NF‑κB signaling pathway

  • Authors:
    • Yunfei Wang
    • Xiaoran Zhang
    • Jianmin Tian
    • Guoze Liu
    • Xiaofang Li
    • Dan Shen
  • View Affiliations

  • Published online on: May 30, 2019     https://doi.org/10.3892/ijmm.2019.4217
  • Pages: 479-490
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Acute lung injury (ALI) is a critical syndrome that is associated with a high morbidity and mortality in patients. Sevoflurane has a lung protective effect in ALI as it reportedly has anti‑inflammatory and apoptotic‑regulating activity. However, the mechanism is still not entirely understood. The aim of the present study was to explore the effects of sevoflurane on lipopolysaccharide (LPS)‑induced ALI in mice and the possible mechanisms involved. The results revealed that sevoflurane treatment improved LPS‑induced lung injury, as evidenced by the reduction in mortality, lung permeability, lung wet/dry ratio and lung histopathological changes in mice. Total cell counts and the production of pro‑inflammatory cytokines [tumor necrosis factor‑α, interleukin (IL)‑1β and IL‑6] in bronchoalveolar fluid were also decreased following treatment with sevoflurane. Additionally, LPS‑triggered apoptosis in lung tissues, which was eliminated by sevoflurane. Furthermore, a miRCURY™ LNA array was employed to screen for differentially expressed microRNAs (miRs/miRNAs). Among these miRNAs, 6 were differentially expressed and were involved in the inflammatory response, but only miR‑27a‑3p (miR‑27a) was regulated by sevoflurane. Subsequently, the present study investigated whether sevoflurane exerts its function through the modulation of miR‑27a. The results demonstrated that the overexpression of miR‑27a via an injection with agomiR‑27a produced similar protections as sevoflurane, while the inhibition of miR‑27a suppressed the lung protective effects of sevoflurane in ALI mice. In addition, the present study identified that miR‑27a inhibited Toll‑like receptor 4 (TLR4) by binding to its 3'‑untranslated region. Western blot analysis demonstrated that sevoflurane may ameliorate the inflammatory response by blocking the miR‑27a/TLR4/MyD88/NF‑κB signaling pathway. The present results indicate that sevoflurane may be a viable therapeutic option in the treatment of patients with ALI.

References

1 

Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ and Hudson LD: Incidence and outcomes of acute lung injury. N Engl J Med. 353:1685–1693. 2005. View Article : Google Scholar : PubMed/NCBI

2 

Brigham KL: Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Curr Infect Dis Rep. 7:327–328. 2005. View Article : Google Scholar : PubMed/NCBI

3 

Bhatia M and Moochhala S: Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J Pathol. 202:145–156. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Grommes J and Soehnlein O: Contribution of neutrophils to acute lung injury. Mol Med. 17:293–307. 2011. View Article : Google Scholar :

5 

Kersten JR, Schmeling TJ, Hettrick DA, Pagel PS, Gross GJ and Warltier DC: Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology. 85:794–807; discussion 27A. 1996. View Article : Google Scholar : PubMed/NCBI

6 

Kersten JR, Schmeling TJ, Pagel PS, Gross GJ and Warltier DC: Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: Reduction of myocardial infarct size with an acute memory phase. Anesthesiology. 87:361–370. 1997. View Article : Google Scholar : PubMed/NCBI

7 

Schlack W, Preckel B, Barthel H, Obal D and Thamer V: Halothane reduces reperfusion injury after regional ischaemia in the rabbit heart in vivo. Br J Anaesth. 79:88–96. 1997. View Article : Google Scholar : PubMed/NCBI

8 

Minguet G, Joris J and Lamy M: Preconditioning and protection against ischaemia-reperfusion in non-cardiac organs: A place for volatile anaesthetics? Eur J Anaesthesiol. 24:733–745. 2007. View Article : Google Scholar : PubMed/NCBI

9 

Kalimeris K, Zerva A, Matsota P, Nomikos T, Fragopoulou E, Politi AN, Karamitopoulou E and Kostopanagiotou G: Pretreatment with sevoflurane attenuates direct lung injury. Minerva Anestesiol. 80:635–644. 2014.

10 

Liu R, Ishibe Y and Ueda M: Isoflurane-sevoflurane adminstration before ischemia attenuates ischemia-reperfusion-induced injury in isolated rat lungs. Anesthesiology. 92:833–840. 2000. View Article : Google Scholar : PubMed/NCBI

11 

Kalb R, Schober P, Schwarte LA, Weimann J and Loer SA: Preconditioning, but not postconditioning, with Sevoflurane reduces pulmonary neutrophil accumulation after lower body ischaemia/reperfusion injury in rats. Eur J Anaesthesiol. 25:454–459. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Casanova J, Garutti I, Simon C, Giraldez A, Martin B, Gonzalez G, Azcarate L, Garcia C and Vara E: The effects of anesthetic preconditioning with sevoflurane in an experimental lung autotransplant model in pigs. Anesth Analg. 113:742–748. 2011. View Article : Google Scholar : PubMed/NCBI

13 

Suter D, Spahn DR, Blumenthal S, Reyes L, Booy C, Z'graggen BR and Beck-Schimmer B: The immunomodulatory effect of sevoflurane in endotoxin-injured alveolar epithelial cells. Anesth Analg. 104:638–645. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Ohsumi A, Marseu K, Slinger P, McRae K, Kim H, Guan Z, Hwang DM, Liu M, Keshavjee S and Cypel M: Sevoflurane attenuates ischemia-reperfusion injury in a rat lung transplantation model. Ann Thorac Surg. 103:1578–1586. 2017. View Article : Google Scholar : PubMed/NCBI

15 

Sun XJ, Li XQ, Wang XL, Tan WF and Wang JK: Sevoflurane inhibits nuclear factor-κB activation in lipopolysaccha-ride-induced acute inflammatory lung injury via toll-like receptor 4 signaling. PLoS One. 10:e01227522015. View Article : Google Scholar

16 

Song SY, Zhou B, Yang SM, Liu GZ, Tian JM and Yue XQ: Preventive effects of sevoflurane treatment on lung inflammation in rats. Asian Pac J Trop Med. 6:53–56. 2013. View Article : Google Scholar : PubMed/NCBI

17 

Bartel DP: MicroRNAs: Target recognition and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI

18 

Stefani G and Slack FJ: Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Guo Z, Gu Y, Wang C, Zhang J, Shan S, Gu X, Wang K, Han Y and Ren T: Enforced expression of miR-125b attenuates LPS-induced acute lung injury. Immunol Lett. 162:18–26. 2014. View Article : Google Scholar : PubMed/NCBI

20 

Chen W, Ma X, Zhang P, Li Q, Liang X and Liu J: MiR-212 3p inhibits LPS-induced inflammatory response through targeting HMGB1 in murine macrophages. Exp Cell Res. 350:318–326. 2017. View Article : Google Scholar

21 

Lv X, Yan J, Jiang J, Zhou X, Lu Y and Jiang H: MicroRNA-27a 3p suppression of peroxisome proliferator-activated receptor-γ contributes to cognitive impairments resulting from sevoflurane treatment. J Neurochem. 143:306–319. 2017. View Article : Google Scholar : PubMed/NCBI

22 

Wu Y, Gu C and Huang X: Sevoflurane protects against hepatic ischemia/reperfusion injury by modulating microRNA-200c regulation in mice. Biomed Pharmacother. 84:1126–1136. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Wenlan L, Zhongyuan X, Shaoqing L, Liying Z, Bo Z and Min L: MiR-34a-5p mediates sevoflurane preconditioning induced inhibition of hypoxia/reoxygenation injury through STX1A in cardiomyocytes. Biomed Pharmacother. 102:153–159. 2018. View Article : Google Scholar : PubMed/NCBI

24 

Beck-Schimmer B, Madjdpour C, Kneller S, Ziegler U, Pasch T, Wüthrich RP, Ward PA and Schimmer RC: Role of alveolar epithelial ICAM-1 in lipopolysaccharide-induced lung inflammation. Eur Respir J. 19:1142–1150. 2002. View Article : Google Scholar : PubMed/NCBI

25 

Wang L, Ye Y, Su HB and Yang JP: The anesthetic agent sevoflurane attenuates pulmonary acute lung injury by modulating apoptotic pathways. Braz J Med Biol Res. 50:e57472017. View Article : Google Scholar : PubMed/NCBI

26 

Cao YZ, Tu YY, Chen X, Wang BL, Zhong YX and Liu MH: Protective effect of Ulinastatin against murine models of sepsis: Inhibition of TNF-α and IL-6 and augmentation of IL-10 and IL-13. Exp Toxicol Pathol. 64:543–547. 2012. View Article : Google Scholar

27 

Gao C, Li R and Wang S: Ulinastatin protects pulmonary tissues from lipopolysaccharide-induced injury as an immunomodulator. J Trauma Acute Care Surg. 72:169–176. 2012.

28 

Luo Y, Che W and Zhao M: Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells. Int J Mol Med. 39:297–306. 2017. View Article : Google Scholar :

29 

Xu Z, Zhang C, Cheng L, Hu M, Tao H and Song L: The microRNA miR-17 regulates lung FoxA1 expression during lipopolysaccharide-induced acute lung injury. Biochem Biophys Res Commun. 445:48–53. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Duan Y, Learoyd J, Meliton AY, Leff AR and Zhu X: Inhibition of Pyk2 blocks lung inflammation and injury in a mouse model of acute lung injury. Respir Res. 13:42012. View Article : Google Scholar : PubMed/NCBI

31 

Barreto TR, Costola-de-Souza C, Margatho RO, Queiroz-Hazarbassanov N, Rodrigues SC, Felício LF, Palermo-Neto J and Zager A: Repeated Domperidone treatment modulates pulmonary cytokines in LPS-induced acute lung injury in mice. Int Immunopharmacol. 56:43–50. 2018. View Article : Google Scholar : PubMed/NCBI

32 

Yang Q, Zhang D and Li Y and Li Y and Li Y: Paclitaxel alleviated liver injury of septic mice by alleviating inflammatory response via microRNA-27a/TAB3/NF-κB signaling pathway. Biomed Pharmacother. 97:1424–1433. 2018. View Article : Google Scholar

33 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

34 

Luo C, Yuan D, Zhao W, Chen H, Luo G, Su G and Hei Z: Sevoflurane ameliorates intestinal ischemia-reperfusion-induced lung injury by inhibiting the synergistic action between mast cell activation and oxidative stress. Mol Med Rep. 12:1082–1090. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Liu C, Shen Z, Liu Y, Peng J, Miao L, Zeng W and Li Y: Sevoflurane protects against intestinal ischemia-reperfusion injury partly by phosphatidylinositol 3 kinases/Akt pathway in rats. Surgery. 157:924–933. 2015. View Article : Google Scholar : PubMed/NCBI

36 

Zhao W, Gan X, Su G, Wanling G, Li S, Hei Z, Yang C and Wang H: The interaction between oxidative stress and mast cell activation plays a role in acute lung injuries induced by intestinal ischemia-reperfusion. J Surg Res. 187:542–552. 2014. View Article : Google Scholar

37 

Zhou T, Garcia JG and Zhang W: Integrating microRNAs into a system biology approach to acute lung injury. Transl Res. 157:180–190. 2011. View Article : Google Scholar : PubMed/NCBI

38 

Martin GS: Sepsis, severe sepsis and septic shock: Changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. 10:701–706. 2012. View Article : Google Scholar : PubMed/NCBI

39 

Huang RS, Hu GQ, Lin B, Lin ZY and Sun CC: MicroRNA-155 silencing enhances inflammatory response and lipid uptake in oxidized low-density lipoprotein-stimulated human THP-1 macrophages. J Investig Med. 58:961–967. 2010. View Article : Google Scholar : PubMed/NCBI

40 

Wu DP, Zhang JL, Wang JY, Cui MX, Jia JL, Liu XH and Liang QD: MiR-1246 promotes LPS-induced inflammatory injury in chondrogenic cells ATDC5 by targeting HNF4γ. Cell Physiol Biochem. 43:2010–2021. 2017. View Article : Google Scholar

41 

Zhang Q, Su J, Wang Z, Qi H, Ge Z, Li Z, Chen WD and Wang YD: MicroRNA-149* suppresses hepatic inflammatory response through antagonizing STAT3 signaling pathway. Oncotarget. 8:65397–65406. 2017.PubMed/NCBI

42 

Satishchandran A, Ambade A, Rao S, Hsueh YC, Iracheta-Vellve A, Tornai D, Lowe P, Gyongyosi B, Li J, Catalano D, et al: MicroRNA 122, regulated by GRLH2, protects livers of mice and patients from ethanol-induced liver disease. Gastroenterology. 154:238–252.e7. 2018. View Article : Google Scholar

43 

Chen H, Li X, Liu S, Gu L and Zhou X: MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis. Sci Rep. 7:120892017. View Article : Google Scholar : PubMed/NCBI

44 

Lo WY, Peng CT and Wang HJ: MicroRNA-146a-5p mediates high glucose-induced endothelial inflammation via targeting interleukin-1 receptor-associated kinase 1 expression. Front Physiol. 8:5512017. View Article : Google Scholar : PubMed/NCBI

45 

Lv YN, Ou-Yang AJ and Fu LS: MicroRNA-27a negatively modulates the inflammatory response in lipopolysaccharide-stimulated microglia by targeting TLR4 and IRAK4. Cell Mol Neurobiol. 37:195–210. 2017. View Article : Google Scholar

46 

Cai Q, Wang T, Yang WJ and Fen X: Protective mechanisms of microRNA-27a against oxygen-glucose deprivation-induced injuries in hippocampal neurons. Neural Regen Res. 11:1285–1292. 2016. View Article : Google Scholar : PubMed/NCBI

47 

Xue WL, Bai X and Zhang L: rhTNFR:Fc increases Nrf2 expression via miR-27a mediation to protect myocardium against sepsis injury. Biochem Biophys Res Commun. 464:855–861. 2015. View Article : Google Scholar : PubMed/NCBI

48 

Wu C, Zhao J, Zhu G, Huang Y and Jin L: SiRNA directed against NF-κB inhibits mononuclear macrophage cells releasing proinflammatory cytokines in vitro. Mol Med Rep. 16:9060–9066. 2017. View Article : Google Scholar : PubMed/NCBI

49 

Zhu G, Xin X, Liu Y, Huang Y, Li K and Wu C: Geraniin attenuates LPS-induced acute lung injury via inhibiting NF-κB and activating Nrf2 signaling pathways. Oncotarget. 8:22835–22841. 2017.PubMed/NCBI

50 

Kawasaki T and Kawai T: Toll-like receptor signaling pathways. Front Immunol. 5:4612014. View Article : Google Scholar : PubMed/NCBI

51 

Steurer M, Schläpfer M, Steurer M, Z'graggen BR, Booy C, Reyes L, Spahn DR and Beck-Schimmer B: The volatile anaesthetic sevoflurane attenuates lipopolysaccharide-induced injury in alveolar macrophages. Clin Exp Immunol. 155:224–230. 2009. View Article : Google Scholar :

52 

Voigtsberger S, Lachmann RA, Leutert AC, Schläpfer M, Booy C, Reyes L, Urner M, Schild J, Schimmer RC and Beck-Schimmer B: Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide-induced lung injury. Anesthesiology. 111:1238–1248. 2009. View Article : Google Scholar : PubMed/NCBI

53 

Tang QF, Fang ZY and Shi CH: The protective effect and mechanism of sevoflurane on LPS-induced acute lung injury in mice. Am J Transl Res. 9:1732–1742. 2017.PubMed/NCBI

54 

Schläpfer M, Leutert AC, Voigtsberger S, Lachmann RA, Booy C and Beck-Schimmer B: Sevoflurane reduces severity of acute lung injury possibly by impairing formation of alveolar oedema. Clin Exp Immunol. 168:125–134. 2012. View Article : Google Scholar : PubMed/NCBI

55 

Hofstetter C, Boost KA, Flondor M, Basagan-Mogol E, Betz C, Homann M, Muhl H, Pfeilschifter J and Zwissler B: Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats. Acta Anaesthesiol Scand. 51:893–899. 2007. View Article : Google Scholar : PubMed/NCBI

56 

Tanaka S, Ishikawa M, Arai M, Genda Y and Sakamoto A: Changes in microRNA expression in rat lungs caused by sevoflurane anesthesia: A TaqMan® low-density array study. Biomed Res. 33:255–263. 2012. View Article : Google Scholar

57 

Tang B, Li X, Ren Y, Wang J, Xu D, Hang Y, Zhou T, Li F and Wang L: MicroRNA-29a regulates lipopolysaccharide (LPS)-induced inflammatory responses in murine macrophages through the Akt1/NF-κB pathway. Exp Cell Res. 360:74–80. 2017. View Article : Google Scholar : PubMed/NCBI

58 

Li J, Bao L, Zha D, Zhang L, Gao P, Zhang J and Wu X: Oridonin protects against the inflammatory response in diabetic nephrop-athy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways. Int Immunopharmacol. 55:9–19. 2018. View Article : Google Scholar

59 

Yan J, Li J, Zhang L, Sun Y, Jiang J, Huang Y, Xu H, Jiang H and Hu R: Nrf2 protects against acute lung injury and inflammation by modulating TLR4 and Akt signaling. Free Radic Biol Med. 121:78–85. 2018. View Article : Google Scholar : PubMed/NCBI

60 

Deng G, He H, Chen Z, OuYang L, Xiao X, Ge J, Xiang B, Jiang S and Cheng S: Lianqinjiedu decoction attenuates LPS-induced inflammation and acute lung injury in rats via TLR4/NF-κB pathway. Biomed Pharmacother. 96:148–152. 2017. View Article : Google Scholar : PubMed/NCBI

61 

Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V and Egido J: Inflammation and angiotensin II. Int J Biochem Cell Biol. 35:881–900. 2003. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August 2019
Volume 44 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Wang, Y., Zhang, X., Tian, J., Liu, G., Li, X., & Shen, D. (2019). Sevoflurane alleviates LPS‑induced acute lung injury via the microRNA‑27a‑3p/TLR4/MyD88/NF‑κB signaling pathway. International Journal of Molecular Medicine, 44, 479-490. https://doi.org/10.3892/ijmm.2019.4217
MLA
Wang, Y., Zhang, X., Tian, J., Liu, G., Li, X., Shen, D."Sevoflurane alleviates LPS‑induced acute lung injury via the microRNA‑27a‑3p/TLR4/MyD88/NF‑κB signaling pathway". International Journal of Molecular Medicine 44.2 (2019): 479-490.
Chicago
Wang, Y., Zhang, X., Tian, J., Liu, G., Li, X., Shen, D."Sevoflurane alleviates LPS‑induced acute lung injury via the microRNA‑27a‑3p/TLR4/MyD88/NF‑κB signaling pathway". International Journal of Molecular Medicine 44, no. 2 (2019): 479-490. https://doi.org/10.3892/ijmm.2019.4217